Actualidad

The Conservative-Liberal Democrat coalition released a White Paper in July, setting out proposals for the future direction of the Health Service (NHS). It will bring large-scale structural changes to the NHS as well as a renewed focus on patient outcomes and patient choice. The changes are intended to make the healthcare system more clinically led, with decision making devolved to the ‘front line’ (GPs) rather than with managers. Although the Pharmaceutical Industry has broadly welcomed these proposals, it clearly needs to start to engage more with this potential key-actors and should already be seeking relationships with those ‘thought leading’ GPs who may end up leading the GP consortia.

Turbulent international events and a struggling economy at home provided a difficult setting for the UK Chancellor George Osborne’s second budget in the top job. If it fails to deliver growth, then Britain’s economic future will be as precarious as the Chancellor’s political reputation.